Works matching IS 2044-5385 AND VI 15 AND IP 1 AND DT 2025

Results: 69
    1
    2
    3

    Risk of lymphoid malignancy associated with cancer predisposition genes.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01283-z
    By:
    • Boddicker, Nicholas J.;
    • Mwangi, Raphael;
    • Robinson, Dennis P.;
    • Allmer, Cristine;
    • Rosenthal, Allison C.;
    • Habermann, Thomas M.;
    • Feldman, Andrew L.;
    • Rimsza, Lisa M.;
    • King, Rebecca L.;
    • Larson, Melissa C.;
    • Negaard, Bri J.;
    • Norman, Aaron D.;
    • Rajkumar, Nikhil;
    • Ansell, Stephen M.;
    • Dispenzieri, Angela;
    • Murray, David L.;
    • Rajkumar, Vincent;
    • Kumar, Shaji;
    • Abeykoon, Jithma P.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    4
    5
    6

    Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study.

    Published in:
    2025
    By:
    • Pérez-Lamas, Lucía;
    • Segura Diaz, Adrián;
    • García Delgado, Regina;
    • Álvarez-Larrán, Alberto;
    • Senin, María Alicia;
    • Mora, Elvira;
    • Fox, María Laura;
    • Pastor Galan, Irene;
    • Azaceta, Gemma;
    • Garrido Paniagua, Sara;
    • Pérez Lopez, Raúl;
    • Trejos Carvajal, Diana Margarita;
    • Angona, Anna;
    • Albo López, Carmen;
    • Lorente Alegre, Pablo;
    • Vara, Miriam;
    • Vera Goñi, Juan Antonio;
    • De Miguel Llorente, Dunia;
    • Fernández Rodríguez, Ángeles;
    • Marín Sanchez, Alberto
    Publication type:
    Letter
    7

    Reduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01269-x
    By:
    • Willekens, Christophe;
    • Bazinet, Alexandre;
    • Chraibi, Samy;
    • Bataller, Alex;
    • Decroocq, Justine;
    • Arani, Naszrin;
    • Carpentier, Benjamin;
    • Rausch, Caitlin;
    • Lebon, Delphine;
    • Maiti, Abhishek;
    • Gauthier, Nicolas;
    • Short, Nicholas;
    • Bonnet, Sarah;
    • Sasaki, Koji;
    • Khalife-Hachem, Sabine;
    • Swaminathan, Mahesh;
    • Micol, Jean-Baptiste;
    • Pasquier, Florence;
    • Marzac, Christophe;
    • Roos-Weil, Damien
    Publication type:
    Article
    8
    9
    10

    Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01271-3
    By:
    • Sawalha, Y.;
    • Sarosiek, S.;
    • Welkie, R. L.;
    • Seif, S.;
    • Thapa, S.;
    • Zanwar, S.;
    • Cahill, K.;
    • Treitman, R.;
    • Shah, H.;
    • Arora, S.;
    • Pongas, G.;
    • Winter, A.;
    • Major, A.;
    • Riedell, P. A.;
    • Palomba, M. L.;
    • Kapoor, P.;
    • Grajales-Cruz, A.;
    • Shain, K. H.;
    • Thomas, S. K.;
    • Castillo, J. J.
    Publication type:
    Article
    11

    CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01273-1
    By:
    • Luna, Alejandro;
    • Devlin, Sean M.;
    • Rejeski, Kai;
    • Flynn, Jessica R.;
    • Corona, Magdalena;
    • Luttwak, Efrat;
    • Rivas-Delgado, Alfredo;
    • Landego, Ivan;
    • Cassanello, Giulio;
    • Gomez-Llobell, Marina;
    • Raj, Sandeep S.;
    • Dahi, Parastoo B.;
    • Lin, Richard J.;
    • Parascondola, Allison;
    • Palomba, M.Lia;
    • Shah, Gunjan L.;
    • Scordo, Michael;
    • Alarcon Tomas, Ana;
    • Leithner, Doris;
    • Bedmutha, Akshay
    Publication type:
    Article
    12

    Cardiovascular adverse events and outcomes after anti-BCMA CAR-T for relapsed and refractory multiple myeloma.

    Published in:
    2025
    By:
    • Palfi, Stefanie;
    • Peres, Lauren C.;
    • Koelmeyer, Himara;
    • Alsina, Melissa;
    • Baz, Rachid C.;
    • Blue, Brandon J.;
    • Corallo, Salvatore;
    • De Avila, Gabriel;
    • Freeman, Ciara;
    • Gonzalez, Rebecca;
    • Grajales-Cruz, Ariel;
    • Harvey, Kristy;
    • Liu, Hien D.;
    • Nishihori, Taiga;
    • Oliveira, Guilherme H.;
    • Oswald, Laura B.;
    • Castaneda Puglianini, Omar;
    • Selvakumar, Sruthi;
    • Sharma, Alexis Behne;
    • Wang, Elicia
    Publication type:
    Letter
    13
    14
    15

    Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01264-2
    By:
    • Bolarinwa, Abiola;
    • Nagaraj, Madhu;
    • Zanwar, Saurabh;
    • Abdallah, Nadine;
    • Bergsagel, P. Leif;
    • Binder, Moritz;
    • Buadi, Francis;
    • Chhabra, Saurabh;
    • Cook, Joselle;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Leung, Nelson;
    • Lin, Yi;
    • Muchtar, Eli;
    • Parrondo, Ricardo
    Publication type:
    Article
    16

    Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01260-6
    By:
    • Lussana, Federico;
    • Magnani, Chiara F.;
    • Galimberti, Stefania;
    • Gritti, Giuseppe;
    • Gaipa, Giuseppe;
    • Belotti, Daniela;
    • Cabiati, Benedetta;
    • Napolitano, Sara;
    • Ferrari, Silvia;
    • Moretti, Alex;
    • Buracchi, Chiara;
    • Borleri, Gian Maria;
    • Rambaldi, Benedetta;
    • Rizzuto, Giuliana;
    • Grassi, Anna;
    • Paganessi, Muriel;
    • Meli, Cristian;
    • Tettamanti, Sarah;
    • Risca, Giulia;
    • Pais, Giulia
    Publication type:
    Article
    17

    VEN in combination with 10-day DEC in newly diagnosed elderly or relapsed/refractory acute myeloid leukemia, and high-risk myelodysplastic syndrome: long term follow-up of a phase 2 trial.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01265-1
    By:
    • Swaminathan, Mahesh;
    • DiNardo, Courtney D.;
    • Maiti, Abhishek;
    • Pemmaraju, Naveen;
    • Ohanian, Maro;
    • Daver, Navel G.;
    • Garcia-Manero, Guillermo;
    • Issa, Ghayas C.;
    • Borthakur, Gautam;
    • Ravandi, Farhad;
    • Montalban-Bravo, Guillermo;
    • Kadia, Tapan M.;
    • Alvarado, Yesid;
    • Jabbour, Elias J.;
    • Short, Nicholas J.;
    • Wierda, William G.;
    • Jain, Nitin;
    • Kornblau, Steven M.;
    • Masarova, Lucia;
    • Pierce, Sherry A.
    Publication type:
    Article
    18

    Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score–matched study.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01245-5
    By:
    • Bataller, Alex;
    • Sasaki, Koji;
    • Urrutia, Samuel;
    • Montalban-Bravo, Guillermo;
    • Bazinet, Alexandre;
    • Chien, Kelly;
    • Hammond, Danielle;
    • Bouligny, Ian M.;
    • Swaminathan, Mahesh;
    • Issa, Ghayas;
    • Short, Nicholas;
    • Daver, Naval;
    • DiNardo, Courtney D.;
    • Kadia, Tapan;
    • Jabbour, Elias;
    • Ravandi, Farhad;
    • Roboz, Gail J.;
    • Savona, Michael;
    • Griffiths, Elizabeth A.;
    • McCloskey, James
    Publication type:
    Article
    19

    Symptom burden in myeloproliferative neoplasms: clinical correlates, dynamics, and survival impact—a study of 784 patients from the Quebec MPN research group.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01234-8
    By:
    • Poullet, Alisa;
    • Busque, Lambert;
    • Sirhan, Shireen;
    • Delage, Robert;
    • Cournoyer, Ghislain;
    • Chamakhi, Ines;
    • Talbot, Danielle;
    • Mollica, Luigina;
    • Marceau, Daniele;
    • Ethier, Vincent;
    • Desjardins, Pierre;
    • Olney, Harold J.;
    • Harnois, Michaël;
    • Szuber, Natasha
    Publication type:
    Article
    20

    Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score–matched study.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01245-5
    By:
    • Bataller, Alex;
    • Sasaki, Koji;
    • Urrutia, Samuel;
    • Montalban-Bravo, Guillermo;
    • Bazinet, Alexandre;
    • Chien, Kelly;
    • Hammond, Danielle;
    • Bouligny, Ian M.;
    • Swaminathan, Mahesh;
    • Issa, Ghayas;
    • Short, Nicholas;
    • Daver, Naval;
    • DiNardo, Courtney D.;
    • Kadia, Tapan;
    • Jabbour, Elias;
    • Ravandi, Farhad;
    • Roboz, Gail J.;
    • Savona, Michael;
    • Griffiths, Elizabeth A.;
    • McCloskey, James
    Publication type:
    Article
    21

    Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01263-3
    By:
    • Pullarkat, Vinod;
    • Pratz, Keith W.;
    • Döhner, Hartmut;
    • Recher, Christian;
    • Thirman, Michael J.;
    • DiNardo, Courtney D.;
    • Fenaux, Pierre;
    • Schuh, Andre C.;
    • Wei, Andrew H.;
    • Pigneux, Arnaud;
    • Jang, Jun-Ho;
    • Juliusson, Gunnar;
    • Miyazaki, Yasushi;
    • Selleslag, Dominik;
    • Arellano, Martha L.;
    • Liu, Chenglong;
    • Ridgeway, Jean A.;
    • Potluri, Jalaja;
    • Schuler, Jovita;
    • Konopleva, Marina
    Publication type:
    Article
    22
    23
    24

    Deep immune cell profiling in blood and bone marrow of early stage monoclonal gammopathy: an iStopMM and ECRIN-M3 collaborative study.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01255-3
    By:
    • Pérez-Escurza, Oihane;
    • Flores-Montero, Juan;
    • Óskarsson, Jón Þórir;
    • Sanoja-Flores, Luzalba;
    • Pozo, Julio;
    • Lécrevisse, Quentin;
    • Martín, Silvia;
    • Reed, Elín Ruth;
    • Hákonardóttir, Guðlaug Katrín;
    • Harding, Stephen;
    • Þorsteinsdóttir, Sigrún;
    • Rögnvaldsson, Sæmundur;
    • Love, Thorvardur Jon;
    • Durie, Brian;
    • Kristinsson, Sigurdur Yngvi;
    • Orfao, Alberto
    Publication type:
    Article
    25
    26

    Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01248-2
    By:
    • Soureas, Konstantinos;
    • Malandrakis, Panagiotis;
    • Papadimitriou, Maria-Alexandra;
    • Minopoulos, Christos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Liacos, Christine-Ivy;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Scorilas, Andreas;
    • Avgeris, Margaritis;
    • Terpos, Evangelos
    Publication type:
    Article
    27

    Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01250-8
    By:
    • Karmali, Reem;
    • Shouse, Geoffrey;
    • Torka, Pallawi;
    • Moyo, Tamara K.;
    • Romancik, Jason;
    • Barta, Stefan K.;
    • Bhansali, Rahul;
    • Cohen, Jonathon B.;
    • Shah, Nirav N.;
    • Zurko, Joanna;
    • Kenkre, Vaishalee P.;
    • Hess, Brian;
    • Stephens, Deborah M.;
    • Fitzgerald, Lindsey;
    • Ollila, Thomas;
    • Tabiti, Bukky;
    • Roy, Ishan;
    • Ma, Shuo;
    • Winter, Jane;
    • Pro, Barbara
    Publication type:
    Article
    28
    29

    Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC).

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01223-x
    By:
    • Jiménez-Vicente, Carlos;
    • Esteve, Jordi;
    • Baile-González, Mónica;
    • Pérez-López, Estefanía;
    • Martin Calvo, Carmen;
    • Aparicio, Clara;
    • Oiartzabal Ormategi, Itziar;
    • Esquirol, Albert;
    • Peña-Muñoz, Felipe;
    • Fernández-Luis, Sara;
    • Heras Fernando, Inmaculada;
    • González-Rodríguez, Ana Pilar;
    • López-García, Alberto;
    • López-Lorenzo, Jose Luis;
    • Torrado, Tamara;
    • Sáez Marín, Adolfo Jesús;
    • Acosta Fleytas, Cynthia;
    • García, Lucía;
    • Villar, Sara;
    • Filaferro, Silvia
    Publication type:
    Article
    30

    Superior preclinical efficacy of co-treatment with BRG1/BRM and FLT3 inhibitor against AML cells with FLT3 mutations.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01251-7
    By:
    • Fiskus, Warren;
    • Mill, Christopher P.;
    • Piel, Jessica;
    • Collins, Mike;
    • Hentemann, Murphy;
    • Cuglievan, Branko;
    • Birdwell, Christine E.;
    • Das, Kaberi;
    • Hou, Hanxi;
    • Davis, John A.;
    • Jain, Antrix;
    • Malovannaya, Anna;
    • Kadia, Tapan M.;
    • Daver, Naval;
    • Sasaki, Koji;
    • Takahashi, Koichi;
    • Hammond, Danielle;
    • Reville, Patrick K.;
    • Flores, Lauren B.;
    • Loghavi, Sanam
    Publication type:
    Article
    31

    Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01257-1
    By:
    • Voorhees, Timothy J.;
    • McLaughlin, Eric M.;
    • Torka, Pallawi;
    • Florindez, Jorge;
    • Kim, Na Hyun;
    • Moyo, Tamara K.;
    • Reves, Heather;
    • Sumransub, Nuttavut;
    • Deshpande, Saarang;
    • Rose, Ashley;
    • Duarte, Cassandra;
    • Faisal, Muhammad Salman;
    • Hamid, Showkat;
    • Subbiah, Suki;
    • Ayyappan, Sabarish;
    • Shea, Lauren;
    • Cortese, Matt;
    • Patel, Krish;
    • Major, Ajay;
    • Saeed, Hayder
    Publication type:
    Article
    32
    33

    Switching TKIs during CML therapy is frequent, mostly driven by intolerance, and does not affect survival: a prospective Quebec registry study.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01242-8
    By:
    • Busque, Lambert;
    • Beaudet, Marc-Étienne;
    • Harnois, Michaël;
    • Moussa, Hanane;
    • Szuber, Natasha;
    • Mollica, Luigina;
    • Delage, Robert;
    • Olney, Harold;
    • Laneuville, Pierre;
    • Cournoyer, Ghislain;
    • Chamakhi, Inès;
    • Lalancette, Marc;
    • Talbot, Danielle;
    • Ethier, Vincent;
    • Desjardins, Pierre;
    • Assouline, Sarit
    Publication type:
    Article
    34
    35
    36

    Switching TKIs during CML therapy is frequent, mostly driven by intolerance, and does not affect survival: a prospective Quebec registry study.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01242-8
    By:
    • Busque, Lambert;
    • Beaudet, Marc-Étienne;
    • Harnois, Michaël;
    • Moussa, Hanane;
    • Szuber, Natasha;
    • Mollica, Luigina;
    • Delage, Robert;
    • Olney, Harold;
    • Laneuville, Pierre;
    • Cournoyer, Ghislain;
    • Chamakhi, Inès;
    • Lalancette, Marc;
    • Talbot, Danielle;
    • Ethier, Vincent;
    • Desjardins, Pierre;
    • Assouline, Sarit
    Publication type:
    Article
    37
    38

    Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience from hematology cancer consortium.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01240-w
    By:
    • Rajendra, Akhil;
    • Sengar, Manju;
    • Korula, Anu;
    • Ganesan, Prasanth;
    • Jain, Hasmukh;
    • K, Divya;
    • Samuel, Prasanna;
    • Perumal Kalaiyarasi, Jayachandran;
    • Prakash, Gaurav;
    • John, M. Joseph;
    • Palassery, Rasmi;
    • Nair, Chandran K.;
    • Shet, Tanuja;
    • Selvarajan, Sushil;
    • Nayak, Lingaraj;
    • Karunakaran, Parathan;
    • Fouzia, N. A.;
    • Prakash, Om;
    • Bagal, Bhausaheb;
    • Mehra, Nikita
    Publication type:
    Article
    39
    40
    41
    42

    Risk factors for CAR T-cell manufacturing failure and patient outcomes in large B-cell lymphoma: a report from the UK National CAR T Panel.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01225-9
    By:
    • Dulobdas, Vaishali;
    • Kirkwood, Amy A.;
    • Serpenti, Fabio;
    • Gautama, Brijesh;
    • Panopoulou, Aikaterini;
    • Mathew, Amrith;
    • Gabriel, Sumantha;
    • Malladi, Ram;
    • Pealing, Jessica;
    • Bonney, Denise;
    • Nicholson, Emma;
    • Besley, Caroline;
    • Ghorashian, Sara;
    • Kuhnl, Andrea;
    • Davies, Elizabeth;
    • Chappell, Jackie;
    • Black, Anne;
    • Menne, Tobias;
    • O'Reilly, Maeve A.;
    • Sanderson, Robin
    Publication type:
    Article
    43

    Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01222-y
    By:
    • Davis, James A.;
    • Snyder, Jordan;
    • Rice, Mikhaila;
    • Moore, Donald C.;
    • Cahoon, Christopher;
    • Julian, Kelley;
    • Wagner, Charlotte B.;
    • Granger, Katelynn;
    • Green, Kimberly M.;
    • Atrash, Shebli;
    • Hill, Hailey;
    • McElwee, Jessica;
    • Elsey, Grace;
    • Khouri, Jack;
    • Rudoni, Joslyn;
    • Mahmoudjafari, Zahra;
    • Nachar, Victoria R.
    Publication type:
    Article
    44

    Risk factors for CAR T-cell manufacturing failure and patient outcomes in large B-cell lymphoma: a report from the UK National CAR T Panel.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01225-9
    By:
    • Dulobdas, Vaishali;
    • Kirkwood, Amy A.;
    • Serpenti, Fabio;
    • Gautama, Brijesh;
    • Panopoulou, Aikaterini;
    • Mathew, Amrith;
    • Gabriel, Sumantha;
    • Malladi, Ram;
    • Pealing, Jessica;
    • Bonney, Denise;
    • Nicholson, Emma;
    • Besley, Caroline;
    • Ghorashian, Sara;
    • Kuhnl, Andrea;
    • Davies, Elizabeth;
    • Chappell, Jackie;
    • Black, Anne;
    • Menne, Tobias;
    • O'Reilly, Maeve A.;
    • Sanderson, Robin
    Publication type:
    Article
    45
    46
    47

    Impact of baseline genetic profile and treatment on outcome and hematological toxicity in CEBPA-mutated AML.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01224-w
    By:
    • Mannelli, Francesco;
    • Piccini, Matteo;
    • Frigeni, Marco;
    • Gianfaldoni, Giacomo;
    • Bencini, Sara;
    • Salmoiraghi, Silvia;
    • Scappini, Barbara;
    • Peruzzi, Benedetta;
    • Caporale, Roberto;
    • Ciolli, Gaia;
    • Crupi, Francesca;
    • Fasano, Laura;
    • Quinti, Elisa;
    • Pasquini, Andrea;
    • Caroprese, Jessica;
    • Vanderwert, Fiorenza;
    • Rotunno, Giada;
    • Pancani, Fabiana;
    • Signori, Leonardo;
    • Tarantino, Danilo
    Publication type:
    Article
    48

    Targeting osteoclasts for treatment of high-risk B-cell acute lymphoblastic leukemia.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01239-3
    By:
    • Kotecha, Rishi S.;
    • Trinder, Sarah M.;
    • Hughes, Anastasia M.;
    • Mullin, Benjamin H.;
    • Rashid, Sarah;
    • Yuan, Jinbo;
    • Xu, Jiake;
    • Duncan, Owen;
    • Skut, Patrycja;
    • Chua, Grace-Alyssa;
    • Singh, Sajla;
    • Oommen, Joyce;
    • Lock, Richard B.;
    • Kees, Ursula R.;
    • Malinge, Sebastien;
    • Kuek, Vincent;
    • Cheung, Laurence C.
    Publication type:
    Article
    49
    50

    Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01236-6
    By:
    • Kittai, Adam S.;
    • Huang, Ying;
    • Miller, Sarah;
    • Allan, John N.;
    • Bhat, Seema A.;
    • Bond, David A.;
    • Brander, Danielle M.;
    • Byrd, John C.;
    • Chavez, Julio C.;
    • Chong, Elise;
    • Davids, Matthew S.;
    • Danilov, Alexey V.;
    • Ding, Wei;
    • Dowling, Mark R.;
    • Dvorak-Kornaus, Kaitlyn;
    • Freedman, Hannah;
    • Hampel, Paul J.;
    • Ho, Carrie;
    • Hwang, Steven R.;
    • Islam, Prioty
    Publication type:
    Article